NGSgo ONCOdentify

Hemato-oncology diagnostic assays

Benefits

  • Hemato-oncology diagnostic assays
  • Targeting leukemia molecular markers

Description

With collaboration with UMC Utrecht, we are currently working on adding in our product portfolio NGSgo ONCOdentify, hemato-oncology diagnostic assays that focus on several leukemia types. The first kit that we are working on will include molecular markers for Myeloproliferative Neoplasms (MPN). This class of neoplasms includes the neoplasm subtypes CML, PV, ET and PMF.

The NGSgo ONCOdentify MPN kit will include the genetic markers JAK2, CALR and MPL. Knowing the presence of mutations on those genes is valuable for predicting prognosis and selecting treatment options.

Downloads

Log in to browse the downloads.